Successful use of Rituximab in Evans syndrome and refractory immune thrombocytopenic purpura

Journal of the Pakistan Medical Association

Volumn 60, Issue 1, 2010, Pages 64-65

  Kashif, Muhammad ^a   Qureshi, Adnan ^a   Adil, Salman Naseem ^a   Khurshid, Mohammad ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISOLONE; RITUXIMAB; STEROID;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE CYTOPENIA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; CLINICAL CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; CYTOPENIA; DIAGNOSTIC VALUE; DISEASE COURSE; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; FEVER; HEMOGLOBIN BLOOD LEVEL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LABORATORY TEST; MENORRHAGIA; PHYSICAL EXAMINATION; RASH; REMISSION; SIDE EFFECT; SPHEROCYTOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADOLESCENT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SYNDROME; YOUNG ADULT;

EID: 74849088276     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Parodi E, Rivetti E, Amendola G, Bisogno G, Calabrese R, Farruggia P et al. Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response Br J Haematol 2009; 144: 552-8.
2. Garvey B. Rituximab in the treatment of autoimmune haematological disorders Br J Haematol 2008; 141: 149-69.
3. Reale LD, Besa EC. Rituximab in autoimmune pancytopenia: a case report and review of literature. Ann Hematol 2007; 86: 913-6.
4. Ramanathan S, Koutts J, Hertzberg MS. Two Cases of Refractory Warm Autoimmune Hemolytic Anemia Treated With Rituximab. Am J Hematol 2005; 78: 123-6.
5. Galor A, O'Brien T. Rituximab treatment for relapsed autoimmune hemolytic anemia in Evans syndrome. Int J Hematol 2003; 78: 335-6.
6. Grossi A, Santini V, Longo G, Balestri F, Rossini Ferrini P. Treatment with anti CD20 antibodies of patients with autoimmune thrombocytopenia with or without haemolytic anemia: worsening in haemoglobin level. Blood 2000; 96:1089a.
7. Shanafelt T, Madueme H, Wolf R, Tefferi A. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia and Evans syndrome. Mayo Clin Proc 2003; 78: 1340-6.
8. Giagounidis AA, Anhuf J, Schneider P, Germing U, Sohngen D, Quabeck K et al. Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study Eur J Haematol 2002; 69: 95-100.
9. Cooper N, Stasi R, Cunningham-Rundles S, Feuerstein MA, Leonard J, Amadori S et al. The efficacy and safety of B-cell depletionwith anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol 2004; 125:232-9.
10. Stasi R, Pagano A, Stipa E, Amadori S. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood 2001; 98: 952-7.